The fabrication of complex engineered tissues remains a grand challenge in regenerative medicine. These complex tissues – bone, cartilage, vasculature, and cardiac – are characterized by dense cellularity, patterned cellular composition, and controlled matrix presentation. Mimicking this native complexity within in vitro cell-based constructs and biomaterial formulations has enormous potential for clinical applications towards repair and regeneration of tissues. The objective of CECT is to address this clinical opportunity by applying three-dimensional (3D) printing strategies to produce novel tissue engineered constructs with transplantation capabilities. CECT brings together research leaders at the University of Maryland, Rice University, and Wake Forest Institute for Regenerative Medicine, known for their strong bioengineering and biofabrication expertise, state-of-the-art resources, and translational experience, to form 3 Technology Research and Development Projects (TR&Ds).

John Fisher Fischell Family Distinguished Professor & Department Chair 301-405-7475 | jpfisher@umd.edu Profile